Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 6/04/21 → 5/04/26 |
Keywords
- clinical trial
- stroke
- treatment efficacy
- treatment safety
Clinical Trial Phase
- Phase III (a & b)
A Multicentre, Randomized, Double-blinded, Placebo-controlled, Parallel Group, Single-dose Design to Determine the Efficacy and Safety of Nerinetide in Participants with Acute Ischemic Stroke Undergoing Endovascular Thrombectomy Excluding Thrombolysis (ESCAPE-NEXT Trial)
- Chandra, Ronil (Primary Chief Investigator (PCI))
Project: Research